{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:50:26Z","timestamp":1789919426280,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.tube.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T17:14:22Z","timestamp":1550078062000},"page":"76-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?"],"prefix":"10.1016","volume":"115","author":[{"given":"Wing Wai","family":"Yew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Chiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.02.004_bib1","series-title":"Global tuberculosis report 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.tube.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diabres.2018.01.018","article-title":"The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV\/TB burden setting","volume":"138","author":"Berkowitz","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.tube.2019.02.004_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/MMBR.00032-13","article-title":"Host-directed therapeutics for tuberculosis: can we harness the host?","volume":"77","author":"Hawn","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.tube.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tips.2015.05.005","article-title":"Exploring the potential of adjunct therapy in tuberculosis","volume":"36","author":"Rayasam","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.tube.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","article-title":"Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies","volume":"18","author":"Tiberi","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2019.02.004_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cytogfr.2013.01.002","article-title":"Autophagy in Mycobacterium tuberculosis infection: a passepartout to flush the intruder out?","volume":"24","author":"Golleti","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.tube.2019.02.004_bib10","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.tube.2016.09.008","article-title":"Metformin: candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients","volume":"101S","author":"Restrepo","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"E1184","DOI":"10.3390\/molecules23051184","article-title":"The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy","volume":"23","author":"Zilinyi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11064-018-2525-8","article-title":"Metformin protects against spinal cord injury by regulating autophagy via the mTOR signaling pathway","volume":"43","author":"Guo","year":"2018","journal-title":"Neurochem Res"},{"key":"10.1016\/j.tube.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00281-015-0537-x","article-title":"Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review","volume":"38","author":"Kiran","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.tube.2019.02.004_bib14","first-page":"1755","article-title":"Metformin inhibits nuclear factor-kB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vivo","volume":"127","author":"Gu","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.tube.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12950-016-0142-3","article-title":"Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes","volume":"13","author":"Chen","year":"2016","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.tube.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.tube.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2019.02.004_bib19","article-title":"The role of metformin in controlling oxidative stress in muscle of diabetic rats","volume":"2016","author":"Diniz Vilela","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.tube.2019.02.004_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183506","article-title":"Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis","volume":"12","author":"Ara\u00fajo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycaemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tube.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2010.11.030","article-title":"Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients","volume":"93","author":"Chakraborty","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.tube.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnu.2012.08.006","article-title":"Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomised clinical trial","volume":"32","author":"Esteghamati","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.tube.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/ars.2017.7122","article-title":"Does metformin protect diabetic patients from oxidative stress and leukocyte-endothelium interactions?","volume":"27","author":"Diaz-Morales","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.tube.2019.02.004_bib25","first-page":"658","article-title":"Metformin: current knowledge","volume":"19","author":"Nasri","year":"2014","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.tube.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/jac\/dkx046","article-title":"Oxidative stress and TB outcomes in patients with diabetes mellitus?","volume":"72","author":"Yew","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/jac\/dkx509","article-title":"Does oxidative stress contribute to adverse outcomes in HIV-associated TB?","volume":"73","author":"Yew","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15171\/jrip.2018.02","article-title":"Metformin: a mini-review to its antioxidative and anti-inflammatory properties","volume":"7","author":"Abbaszadeh","year":"2018","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.tube.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12967-014-0263-5","article-title":"Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets","volume":"12","author":"Vashisht","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.tube.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12967-015-0443-y","article-title":"Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis","volume":"13","author":"Vashisht","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.tube.2019.02.004_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00652-17","article-title":"Metformin adjunctive therapy does not improve the sterilising activity of the first-line antitubercular regimen in mice","volume":"61","author":"Dutta","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.02.004_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/clpt.2010.266","article-title":"Rifampicin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants","volume":"89","author":"Cho","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tube.2019.02.004_bib33","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1128\/AAC.01471-16","article-title":"Moxifloxacin is a potent in vitro inhibitor of OCT- and MATE-mediated transport of metformin and ethambutol","volume":"60","author":"Te Brake","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.02.004_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bjid.2017.01.001","article-title":"Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility","volume":"21","author":"Marupuru","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.tube.2019.02.004_bib35","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chest.2017.11.040","article-title":"The risk of TB in patients with type 2 diabetes initiating metformin vs sulfonylurea treatment","volume":"153","author":"Pan","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.tube.2019.02.004_bib36","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/resp.13338","article-title":"Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes","volume":"23","author":"Lin","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.tube.2019.02.004_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3904\/kjim.2017.249","article-title":"The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus","volume":"33","author":"Lee","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.tube.2019.02.004_bib38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cid\/cix819","article-title":"Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment","volume":"66","author":"Degner","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2019.02.004_bib39","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10096-018-3242-6","article-title":"Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up","volume":"37","author":"Ma","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2019.02.004_bib40","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/db14-1388","article-title":"Association of organic cation transport 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study","volume":"64","author":"Dujic","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.tube.2019.02.004_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.tube.2019.02.004_bib42","doi-asserted-by":"crossref","first-page":"R226","DOI":"10.1186\/cc9376","article-title":"Outcome of severe lactic acidosis associated with metformin accumulation","volume":"14","author":"Friesecke","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.tube.2019.02.004_bib43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2710.2010.01192.x","article-title":"Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements","volume":"36","author":"van Berlo-van de Laar","year":"2011","journal-title":"J Clin Pharm Ther"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218305043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218305043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:24:29Z","timestamp":1694622269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979218305043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":43,"alternative-id":["S1472979218305043"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.02.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}